Successful treatment of synovitis, acne, pustulosis, hyperostosis and osteitis syndrome with ixekizumab.

Xia, RuiYuan; Diao, ZiYue; Zhang, ZhiQin; Liu, Jian; Yin, ZhiQiang

Xia, RuiYuan; Diao, ZiYue; Zhang, ZhiQin; Liu, Jian; Yin, ZhiQiang.

Affiliation

Xia R; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Diao Z; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhang Z; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Liu J; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yin Z; Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Clin Exp Dermatol ; 47(5): 978-980, 2022 May.

Article in En | MEDLINE | ID: mdl-35089610

Subject(s)

Acne Vulgaris; Acquired Hyperostosis Syndrome; Hyperostosis; Osteitis; Synovitis; Acne Vulgaris/drug therapy; Acquired Hyperostosis Syndrome/diagnosis; Acquired Hyperostosis Syndrome/drug therapy; Antibodies, Monoclonal, Humanized; Humans; Osteitis/diagnosis; Osteitis/drug therapy; Synovitis/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Osteitis / Synovitis / Hyperostosis / Acne Vulgaris / Acquired Hyperostosis Syndrome Type of study: Diagnostic_studies Limits: Humans Language: En Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google